Article
- Author:
- Alan P. Lyss, MD
Publish date: October 20, 2020
Dr. Alan P. Lyss recaps an expert panel on adolescents and young adults with lymphoma.
Opinion
- Author:
- Alan P. Lyss, MD
Publish date: October 1, 2020
Dr. Alan Lyss explores the meaning of undertreatment and overtreatment in older adults with cancer.
Article
- Author:
- Alan P. Lyss, MD
Publish date: September 16, 2020
Dr. Alan Lyss reviews a panel discussion about how COVID-19 has affected cancer research.
Article
- Author:
- Alan P. Lyss, MD
Publish date: August 10, 2020
Dr. Alan Lyss reviews data showing how artificial intelligence can help physicians diagnose and treat cancer.
Opinion
- Author:
- Alan P. Lyss, MD
Publish date: July 29, 2020
Dr. Alan P. Lyss examines a review on extrapulmonary manifestations of COVID-19, focusing in on hematologic effec...
News
- Author:
- Alan P. Lyss, MD
Publish date: July 10, 2020
Dr. Alan P. Lyss reviews research into how the aging microenvironment affects tumor cell metabolism, angiogenesis...
Article
- Author:
- Alan P. Lyss, MD
Publish date: June 29, 2020
Dr. Alan P. Lyss reviews research suggesting endotheliopathy may be a marker of COVID-19 severity.
Article
- Author:
- Alan P. Lyss, MD
Publish date: June 18, 2020
Dr. Alan P. Lyss explores the clinical implications of the CheckMate 9LA study.
News
- Author:
- Alan P. Lyss, MD
Publish date: June 2, 2020
Updated results from PREDIX-HER2 have revealed useful research tools, but the findings probably won’t affect clin...
News
- Author:
- Alan P. Lyss, MD
Publish date: May 6, 2020
Capmatinib produced durable responses, even in patients with brain metastases.
News
- Author:
- Alan P. Lyss, MD
Publish date: April 30, 2020
Data from the TERAVOLT registry showed a 34.6% mortality rate among 200 patients with COVID-19 and lung cancer.
Article
- Author:
- Alan P. Lyss, MD
Publish date: April 28, 2020
ESMO’s guidelines for managing breast cancer patients during the pandemic expand upon guidelines issued by other ...
Article
- Author:
- Alan P. Lyss, MD
Publish date: April 23, 2020
The holistic approach the ESMO guidelines promote has never been more critical than during the pandemic.
Article
- Author:
- Alan P. Lyss, MD
Publish date: April 8, 2020
An ACCC webinar provides insights on conducting cancer trials in the time of COVID-19.
News
- Author:
- Alan P. Lyss, MD
Publish date: April 2, 2020
The medical director of the Seattle Cancer Care Alliance offers advice for cancer centers dealing with COVID-19.
